Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: $Mogul who wrote (60979)	1/11/2000 9:12:00 PM
From: ezmoney	Respond to of 108040

Hey all see ACCR today :-) read this ! GREAT POST FROM ACCR BOARD. To: Dave Sullivan who wrote (720) From: steve patagonia Tuesday, Jan 11, 2000 2:51 PM ET Reply # of 722 Well I hope there's news coming. I just think the movement is due to the fact that it's dawning on people that the day of "Click and Call" is coming, where every Business with a website will want this feature. As said on the E-button site: "Your company's web site is a great way to communicate with your customers. But what if those customers could simply click on an icon and establish a live voice connection with your company over the Internet? " THIS WILL become common place but ACCR is not the only company involved by no means. But they have a bit of a jump with this e-button and were awarded "Best buy" by smart money.(Or was it "smart money" by "Best buy". ATT ofcourse has and is developing an internet telephony program but are stuck in a bit of a "Catch 22" . Internet telephony is already stealing millions of dollars of revenue from ATT's long distance business. Though they have to develop it, they realize they're also developing a technology that will almost totally cripple one of their conventional ways of making money-long distance. Telephony will also replace a lot of 1-800 revenue. The other catch is that any hardware improvements ATT makes are improvements for other internet telephony companies as well. A lot of what telephony is about is software as well, which ATT doesn't have much control over. So as you can see these telephony companies (especially ACCR) are well positioned. This run up may be fleeting but I would just relax and hold on. Lots of VC money here apparently too.

To: $Mogul who wrote (60979)	1/11/2000 9:13:00 PM
From: Bouf	Respond to of 108040

Little stock BIG STORY......CMTX...a "BOUF SLEEPER" Take 2 minutes to read ...very nice..stock up to $4 ish today..on small volume....when it gets noticed..hmmmmm :) READ LAST PARAGRAPH..AMAZING! COMTEX Achieves Revenue Milestone $1 Million in Monthly Booked Revenue Reflects New Account Acquisition at Double the Rate of FY1999 ALEXANDRIA, Va.--(BUSINESS WIRE)--Jan. 11, 2000-- COMTEX News Network (OTC BB: CMTX) today announced that it has closed a record 110 new sales agreements in the first two quarters of its fiscal year - more than doubling the number it logged in the same period the previous year. "COMTEX has exceeded its aggressive sales goals for the first two quarters of fiscal 2000," said Deborah Woolum Ikins, COMTEX executive vice president. "We are running in excess of $1 million in booked revenue per month, as demand for the proprietary, value-added and comprehensive news delivery that COMTEX provides is fueled by the growth of the Internet and demand for real-time news." "COMTEX is setting the pace for real-time news delivery on the Internet," Ms. Ikins continued. "COMTEX has experienced 12 consecutive profitable quarters and if current trends continue, 2000 should be a record year for the Company." New distribution channels for COMTEX' real-time news products include, among others, Internet.com, Zacks Investment Research, Strategy.com, phone.com, CBS MarketWatch, iwon.com, Dreyfus Securities, NCAA, Earthlink, Merrill Lynch, Gateway.net, ForAnything.com, JB Oxford, American Express, Citibank, CNBC, ATT Worldnet, Fox Marketwire, T. Rowe Price, TheGlobe.com, Bell South Buzz, The NY Post and SalesLogix. About COMTEX News Network COMTEX News Network, Inc. (OTC BB: CMTX) is the leading real-time news source serving over 400 companies with real-time news to benefit millions of end-users. Each day, COMTEX can electronically sort up to 100,000 stories from over 500 global sources, including The Associated Press, Phillips, Business Wire, United Press International, The Sports Network and South American Business Information, to create its subject-specific CustomWires(R), headline and vertical-market news products. Located in Alexandria, VA, COMTEX can be found on the World Wide Web at comtexnews.net.

To: $Mogul who wrote (60979)	1/11/2000 10:16:00 PM
From: johnsto1	Read Replies (1) \| Respond to of 108040

off yhoo 11 Jan 15:58 Ariad's technology has applications in both genomics, the study of the genes, and gene therapy, the use of gene-based treatments for diseases, said Chief Executive Berger. Genomics has taken center stage recently as the Celera Genomics Group (CRA) and the government's Human Genome Project rush to map the entire human genome. Celera said Monday it has sequenced 90% of all human genetic material in just four months and expects to finish the job by summer. Sequencing, however, is not the main goal. "It's one thing to know the alphabet - that's what genomics tells us - and it's another thing to be able to translate what the words, the genes, mean." says Berger. Ariad's technology, Argent, is a research tool to "study the function or activity of genes being discovered in the Genome Project," he explained. With the knowledge of individual genes' functions, Ariad's scientists can then develop gene therapies to treat disease. The new patents cover Ariad's efforts to develop those treatments: the company's orally-administered Dimerizer drugs, currently under preclinical development for use in the treatment of a number of ailments. The patents also cover Ariad's graft-versus-host disease product, which may improve the safety and effectiveness of certain types of bone marrow transplants by selectively killing the cells responsible for disease. Berger said Ariad will work with other companies and research laboratories to pursue the broad genomic and gene therapy applications of its technology. - Riva Richmond, Dow Jones Newswires, 201-938-4046 (END) DOW JONES NEWS 01-11-00 03:58 PM